标题
Reality CHEK: Understanding the biology and clinical potential of CHK1
作者
关键词
CHK1, Cell cycle, DNA Damage response
出版物
CANCER LETTERS
Volume 497, Issue -, Pages 202-211
出版商
Elsevier BV
发表日期
2020-09-29
DOI
10.1016/j.canlet.2020.09.016
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer
- (2020) Patrycja Gralewska et al. Journal of Hematology & Oncology
- Exploring the Synergy between PARP and CHK1 Inhibition in Matched BRCA2 Mutant and Corrected Cells
- (2020) Hannah L Smith et al. Cancers
- ATR signalling mediates the prosurvival function of phospho-NPM against PIDDosome mediated cell death
- (2020) Disha Hiregange et al. CELLULAR SIGNALLING
- Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death
- (2019) Wei-Hsun Hsu et al. Journal of Thoracic Oncology
- Checkpoint kinase 1 is essential for fetal and adult hematopoiesis
- (2019) Fabian Schuler et al. EMBO REPORTS
- SPRTN protease and checkpoint kinase 1 cross-activation loop safeguards DNA replication
- (2019) Swagata Halder et al. Nature Communications
- Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development
- (2019) Gesuino Angius et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition
- (2019) Kalindi Parmar et al. CLINICAL CANCER RESEARCH
- Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation
- (2018) Yu-Che Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation
- (2018) Ying Ma et al. Molecular Oncology
- Chk1 KA1 domain auto-phosphorylation stimulates biological activity and is linked to rapid proteasomal degradation
- (2018) Eun-Yeung Gong et al. Scientific Reports
- Intramolecular autoinhibition of checkpoint kinase 1 is mediated by conserved basic motifs of the C-terminal kinase–associated 1 domain
- (2017) Ryan P. Emptage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer
- (2017) Ethan Brill et al. Oncotarget
- Chk1 Inhibitor SCH900776 Effectively Potentiates the Cytotoxic Effects of Platinum-Based Chemotherapeutic Drugs in Human Colon Cancer Cells
- (2017) Jarmila Herůdková et al. NEOPLASIA
- Phase I Study of GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in Patients with Refractory Solid Tumors
- (2016) Jeffrey R. Infante et al. CLINICAL CANCER RESEARCH
- Conformational Change of Human Checkpoint Kinase 1 (Chk1) Induced by DNA Damage
- (2016) Xiangzi Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy
- (2016) H. E. Barker et al. MOLECULAR CANCER THERAPEUTICS
- CHK1 as a therapeutic target to bypass chemoresistance in AML
- (2016) Laure David et al. Science Signaling
- CHK1 as a therapeutic target to bypass chemoresistance in AML
- (2016) Laure David et al. Science Signaling
- ATM and ATR signaling at a glance
- (2015) P. Awasthi et al. JOURNAL OF CELL SCIENCE
- Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors
- (2015) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
- (2015) C. King et al. MOLECULAR CANCER THERAPEUTICS
- Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
- (2015) Peter Bai MOLECULAR CELL
- Interaction of Chk1 with Treslin Negatively Regulates the Initiation of Chromosomal DNA Replication
- (2015) Cai Guo et al. MOLECULAR CELL
- ATM and ATR as therapeutic targets in cancer
- (2015) Anika Maria Weber et al. PHARMACOLOGY & THERAPEUTICS
- The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eµ-MYC driven B-cell lymphoma
- (2015) Mike I. Walton et al. Oncotarget
- Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
- (2015) Rosaria Chilà et al. Oncotarget
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
- (2014) Peijing Zhang et al. NATURE CELL BIOLOGY
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia
- (2013) L L Yuan et al. LEUKEMIA
- Causes and consequences of replication stress
- (2013) Michelle K. Zeman et al. NATURE CELL BIOLOGY
- Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1
- (2013) Y.-C. Cheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
- (2012) Cynthia X. Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition
- (2012) Amy D Guertin et al. Cancer Cell International
- Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
- (2012) M. R. Russell et al. CANCER RESEARCH
- MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells
- (2012) W.-J. Wang et al. CANCER RESEARCH
- Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo
- (2012) Laura Carrassa et al. CELL CYCLE
- CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
- (2012) M. I. Walton et al. CLINICAL CANCER RESEARCH
- Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias
- (2012) J. E. Karp et al. CLINICAL CANCER RESEARCH
- CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma
- (2012) Jian Hong et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors
- (2012) Michael Lainchbury et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRL4CDT2 Targets CHK1 for PCNA-Independent Destruction
- (2012) J. Huh et al. MOLECULAR AND CELLULAR BIOLOGY
- P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation
- (2012) Ping Li et al. MOLECULAR BIOLOGY OF THE CELL
- Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
- (2012) S Origanti et al. ONCOGENE
- Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma
- (2012) Oluf Dimitri Røe et al. PLoS One
- Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy
- (2011) M Bartucci et al. CELL DEATH AND DIFFERENTIATION
- Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
- (2011) L. A. Parsels et al. CLINICAL CANCER RESEARCH
- ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression
- (2011) A. Guarini et al. HAEMATOLOGICA
- Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction
- (2011) James D. Orth et al. MOLECULAR BIOLOGY OF THE CELL
- Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening
- (2011) T. J. Guzi et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Development of the Novel Chk1 Inhibitor SCH900776 in Combination with DNA-Damaging Agents and Antimetabolites
- (2011) R. Montano et al. MOLECULAR CANCER THERAPEUTICS
- ATM Mutations in Patients with Hereditary Pancreatic Cancer
- (2011) Nicholas J. Roberts et al. Cancer Discovery
- Knockdown of Chk1 sensitizes human colon carcinoma HCT116 cells in a p53-dependent manner to lidamycin through abrogation of a G2/M checkpoint and induction of apoptosis
- (2010) Yu Pan et al. CANCER BIOLOGY & THERAPY
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2Checkpoint and Inhibition of Homologous Recombinational DNA Repair
- (2010) Meredith A. Morgan et al. CANCER RESEARCH
- New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network
- (2010) Y. Dai et al. CLINICAL CANCER RESEARCH
- 14-3-3γ mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage
- (2010) Kousuke Kasahara et al. EMBO JOURNAL
- Chk1 Haploinsufficiency Results in Anemia and Defective Erythropoiesis
- (2010) Nathan C. Boles et al. PLoS One
- Chk1 promotes replication fork progression by controlling replication initiation
- (2010) E. Petermann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DDB1 Targets Chk1 to the Cul4 E3 Ligase Complex in Normal Cycling Cells and in Cells Experiencing Replication Stress
- (2009) V. Leung-Pineda et al. CANCER RESEARCH
- Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells
- (2009) L. A. Parsels et al. MOLECULAR CANCER THERAPEUTICS
- The F Box Protein Fbx6 Regulates Chk1 Stability and Cellular Sensitivity to Replication Stress
- (2009) You-Wei Zhang et al. MOLECULAR CELL
- NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint
- (2009) Marina Melixetian et al. NATURE CELL BIOLOGY
- G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
- (2008) N Bucher et al. BRITISH JOURNAL OF CANCER
- Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer
- (2008) Martin F. Lavin NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ATR: an essential regulator of genome integrity
- (2008) Karlene A. Cimprich et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage
- (2008) E M Bahassi et al. ONCOGENE
- Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control
- (2008) D. Wilsker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search